Cure.

Under the leadership of CEO Seema Kumar, Cure is proud to support the next generation of innovators in #science and #biotech. The teams dedication to initiatives like #BioGENEius reflects the companys commitment to advancing #healthcare and driving #innovation forward. Together, with our partners like Biotechnology Institute we’re shaping a brighter future for the industry. #futureleaders

Join us next week for Tuesday Talks as we welcome Greg Simon, a renowned cancer advocate and policy expert. Greg previously served as the executive director of the Cancer Moonshot Task Force under the Biden Cancer Initiative. We’ll delve into the latest trends in emerging biotechnology and discuss innovative strategies for advancing healthcare. Don't miss this opportunity to gain valuable insights from one of the top leaders in healthcare! #linkedinlive #cancermoonshot #moonshots #healthcarepolicy

Nearly five years after COVID-19 changed the world, experts reflect on the lessons and missed opportunities the pandemic brought. Read more from Former White House Coronavirus Response Coordinator Deborah Birx, MD, who discussed key successes and critical gaps in handling the #COVID19 #pandemic and how they help prepare us for next time. #wewillcure

This week at #biofuture2024, we sat down with Manolis Kellis a professor at Massachusetts Institute of Technology MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) and Broad Institute of MIT and Harvard, who discussed the current transformation that #AI is making in human health. Watch what he says he is most excited about, and read what he says about where AI is falling short. https://lnkd.in/evvp6QqT

Congratulations to Cure resident company Evommune on the outstanding achievement of closing their Series C. #wewillcure

To address the burgeoning world movement of self-care — helping people help themselves to stay healthy and make preventive care a reality. Cure and Bayer convened academics, diplomats, nonprofit leaders, entrepreneurs, investors, physicians, patients, and activists from around the world shared on-the-ground stories about the urgent need for self-care initiatives and what the activities of their organizations. Bayer's Daniella Foster started out the conversation by saying "For those people who are in a health desert, their first line and last line of care is self-care,” while Ambassador Dr. Malik Nadeem Abid, Secretary General of the International Human Rights Commission-IHRC at the United Nations, talked about “the fundamental human right to self-care” and the challenges in current healthcare systems, stressing the need for legislative changes at national and international levels to promote self-care. He specifically highlighted the importance of cultural tailoring in designing solutions for self-care and health equity. Read more to hear from participants from Clinton Global Initiative, Deloitte, World Health Organization plus more: https://lnkd.in/eFYRTvrf

We couldn't be more excited to host the Biotechnology Institute BioGeneius Challenge Award Ceremony tomorrow, where high school students from across the U.S. have presented biotech-based projects that may help to advance understanding of - and solutions for human disease. At Cure, we know that the future of a healthier world is in the hands of our young scientists and that one day, they will be able to cure, period. #wewillcure #kidsinstem #biofuture2024

Are you looking to build an effective biotech team? On next week's Tuesday Talks, Shalabh Gupta, MD, founder and CEO of Unicycive Therapeutics, will join us to share his unique journey of taking his biotech company public with just one employee. Dr. Gupta will also discuss why building a strong, cohesive team may be the key to long-term success in the biotech industry. This is a not-to-miss episode for all new founders and entrepreneurs. Register today! #linkedinlive #entrepreneurship #teambuilding

Excitement is in the air at Cure this week as we are hosting #BioFuture2024! Today, Cure CEO Seema Kumar kicked off the week with Demy-Colton CEO & Founder, Sara Jane Demy, by introducing the renowned Massachusetts Institute of Technology computational biology professor Manolis Kellis. In a thought-provoking fireside chat journalist David Ewing Duncan and Kellis took a deep look into the real-world impact of #AI in science, exploring whether it can live up to its hype and how it might reshape the work academics have refined for centuries. Stay tuned all week for exclusive content and video at www.wewillcure.com from #biofuture2024!

Last week, Cure proudly partnered with Life Science Cares New York to bring high school students from across NYC together for the second annual Life Sciences Day, in collaboration with the New York City Economic Development Corporation. Students who joined us at Cure experienced hands-on experiment workshops and enjoyed networking lunches with leaders from our Cure resident companies, including Wandercraft, Deerfield Catalyst, Excelsior Sciences, Advancium Health Network, Evommune and Lexeo Therapeutics. At Cure, we believe in the power of the next generation to drive healthcare innovation. As our CEO, Seema Kumar, says: “The future of healthcare innovation lies in the hands of the next generation. Events like Life Sciences Day provide students with the invaluable opportunity to see firsthand how science can transform lives and how their passion and creativity can shape the future.” Thank you to everyone who contributed to this amazing day! Together, we’re inspiring tomorrow’s stem leaders. #NextGenInnovators #STEMEducation #HealthcareInnovation